Buying A Retail Name

“A public opinion poll is no substitute for thought.” ― Warren Buffett The Portfolio Despite a level of uncertainty rarely seen in global markets, our portfolio is holding up well delivering growth, performing better than the S&P 500 and all with lower volatility....so we can Stay Invested. Today's Buys: BOUGHT 200 shares of TLYS @ $7.90/share. Today I did some homework on a retail name, Tilly's. I can't remember a worse time to invest in retail, so that's exactly where I like to look for a possible winner. I like train wrecks, and right now retail in general looks like a train wreck, but there are some stand outs. Most of us see a train wreck as a smoldering pile of junk and destruction.

Buying BioSpecifics Technologies

“In investing, what is comfortable is rarely profitable.” ― Robert Arnott The Portfolio The portfolio is holding up well today, closing just under 12% and still beating the S&P 500, our benchmark index which closed at 11.25% today. Today I did some homework on a healthcare name, BioSpecifics Technologies and liked it enough to buy 25 shares. Today's Buys: BUY 25 shares of BSTC @ $58.81/share. Background BioSpecifics Technologies Corp., is a $429 million biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuy

Shopping Day : )

“The real key to making money in stocks is not to get scared out of them.” ― Peter Lynch The Portfolio Today I took advantage of the market sell off to buy some great companies at reduced prices. I also sold some bank stocks, it's possible we won't see these appreciate anymore as the potential for a rate cut is pretty high. In fact we may see a couple of rate cuts; at least that's what the bond market is telling us today. Please don't restart worrying about the inverted yield curve. CVS is one of my favorite stocks for a long term hold. Everything CVS is doing is designed to benefit from all the changes taking place in US healthcare and will benefit everyone in ways not yet imagined. Wh

We're At War - Stay Invested

“In the West you have the notion that if somebody hits you on the left cheek, you turn the other cheek, In our culture, we punch back.” ― Xi Jingping General Secretary of the Communist Party of China The Portfolio Today's rally gave the portfolio a little bump and pushed it above 7%. I haven't been saying too much about the portfolio because its running live it's there for everyone to see all day long. Please let me know if you want more commentary. The biggest change is today is I bought Nabriva Therapeutics (NBRV) this morning at $2.65 per share. NBRV closed today at $2.75; this pushed the blog performance above 9%. My twelve month price target on this company is $12.50, but I think it

Keep Selling, I'm Buying

“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful.” ― Warren Buffett The Sell Off Today was one of those days, the DOW sold off 617 points (2.38%), the S&P 500 sold off 69.5 points (2.41%) and the tech heavy NASDAQ sold off 270 points (.18%). Even if you don't follow the markets regularly, these numbers probably caught your attention today. Today's emails from readers, "Clay! Say something!" "No posts since April! Speak already". The market is full of pundits who cry the sky is falling everyday and then rejoice when a day like today finally occurs just to say, "See I was right". Those same voices are probably quietly buying shares of their favorite companies. Clay's

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • LinkedIn Social Icon
  • Google+ Social Icon
  • Twitter Social Icon
  • Facebook Social Icon

This material is provided for informational purposes only, as of the date hereof, and is subject to change without notice.
This material may not be suitable for all investors and is not intended to be an offer, or the solicitation of any offer, to buy or sell any securities.

© 2016 by Clay Baker all rights reserved